EMEA (Europe, Middle East and Africa) Transmucosal Drug Delivery Market Report 2018

March 2018 | 125 pages | ID: ECE7E3B6996EN
QYResearch

Abstracts

In this report, the EMEA Transmucosal Drug Delivery market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Transmucosal Drug Delivery for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Transmucosal Drug Delivery market competition by top manufacturers/players, with Transmucosal Drug Delivery sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• 3M Pharmaceuticals
• Acrux Limited
• ALZA Corporation
• Antares Pharma, Inc.
• Apricus BioSciences, Inc
• Aveva Drug Delivery Systems
• Corium International, Inc
• DURECT Corporation
• Generex Biotechnology Corporation
• Inovio Pharmaceuticals, Inc.
• Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
• MedPharm LTD
• Mylan, Inc.
• Nemaura Pharma Ltd
• Nitto Denko Corporation
• Noven Pharmaceuticals, Inc.
• Pantec Biosolutions AG
• Tapemark
• tesa Labtec GmbH
• TEVA Pharmaceutical Industries Ltd.
• Zosano Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Passive Transdermal Drug Delivery
• Active Transdermal Drug Delivery

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Transmucosal Drug Delivery Market Report 2018

1 TRANSMUCOSAL DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Transmucosal Drug Delivery
1.2 Classification of Transmucosal Drug Delivery
  1.2.1 EMEA Transmucosal Drug Delivery Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Transmucosal Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Passive Transdermal Drug Delivery
  1.2.4 Active Transdermal Drug Delivery
1.3 EMEA Transmucosal Drug Delivery Market by Application/End Users
  1.3.1 EMEA Transmucosal Drug Delivery Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 EMEA Transmucosal Drug Delivery Market by Region
  1.4.1 EMEA Transmucosal Drug Delivery Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Transmucosal Drug Delivery (2013-2025)
  1.5.1 EMEA Transmucosal Drug Delivery Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Transmucosal Drug Delivery Revenue and Growth Rate (2013-2025)

2 EMEA TRANSMUCOSAL DRUG DELIVERY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Transmucosal Drug Delivery Market Competition by Players/Manufacturers
  2.1.1 EMEA Transmucosal Drug Delivery Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Transmucosal Drug Delivery Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Transmucosal Drug Delivery Sale Price by Players (2013-2018)
2.2 EMEA Transmucosal Drug Delivery (Volume and Value) by Type/Product Category
  2.2.1 EMEA Transmucosal Drug Delivery Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Transmucosal Drug Delivery Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Transmucosal Drug Delivery Sale Price by Type (2013-2018)
2.3 EMEA Transmucosal Drug Delivery (Volume) by Application
2.4 EMEA Transmucosal Drug Delivery (Volume and Value) by Region
  2.4.1 EMEA Transmucosal Drug Delivery Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Transmucosal Drug Delivery Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Transmucosal Drug Delivery Sales Price by Region (2013-2018)

3 EUROPE TRANSMUCOSAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Transmucosal Drug Delivery Sales and Value (2013-2018)
  3.1.1 Europe Transmucosal Drug Delivery Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Transmucosal Drug Delivery Revenue and Growth Rate (2013-2018)
3.2 Europe Transmucosal Drug Delivery Sales and Market Share by Type
3.3 Europe Transmucosal Drug Delivery Sales and Market Share by Application
3.4 Europe Transmucosal Drug Delivery Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Transmucosal Drug Delivery Sales Volume by Countries (2013-2018)
  3.4.2 Europe Transmucosal Drug Delivery Revenue by Countries (2013-2018)
  3.4.3 Germany Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.4 France Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.5 UK Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.6 Russia Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.7 Italy Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)

4 MIDDLE EAST TRANSMUCOSAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Transmucosal Drug Delivery Sales and Value (2013-2018)
  4.1.1 Middle East Transmucosal Drug Delivery Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Transmucosal Drug Delivery Revenue and Growth Rate (2013-2018)
4.2 Middle East Transmucosal Drug Delivery Sales and Market Share by Type
4.3 Middle East Transmucosal Drug Delivery Sales and Market Share by Application
4.4 Middle East Transmucosal Drug Delivery Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Transmucosal Drug Delivery Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Transmucosal Drug Delivery Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  4.4.4 Israel Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  4.4.5 UAE Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  4.4.6 Iran Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)

5 AFRICA TRANSMUCOSAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Transmucosal Drug Delivery Sales and Value (2013-2018)
  5.1.1 Africa Transmucosal Drug Delivery Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Transmucosal Drug Delivery Revenue and Growth Rate (2013-2018)
5.2 Africa Transmucosal Drug Delivery Sales and Market Share by Type
5.3 Africa Transmucosal Drug Delivery Sales and Market Share by Application
5.4 Africa Transmucosal Drug Delivery Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Transmucosal Drug Delivery Sales Volume by Countries (2013-2018)
  5.4.2 Africa Transmucosal Drug Delivery Revenue by Countries (2013-2018)
  5.4.3 South Africa Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Transmucosal Drug Delivery Sales and Growth Rate (2013-2018)

6 EMEA TRANSMUCOSAL DRUG DELIVERY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 3M Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Acrux Limited
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Acrux Limited Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 ALZA Corporation
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 ALZA Corporation Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Antares Pharma, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Apricus BioSciences, Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Aveva Drug Delivery Systems
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Corium International, Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Corium International, Inc Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 DURECT Corporation
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 DURECT Corporation Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Generex Biotechnology Corporation
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Inovio Pharmaceuticals, Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Transmucosal Drug Delivery Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
6.12 MedPharm LTD
6.13 Mylan, Inc.
6.14 Nemaura Pharma Ltd
6.15 Nitto Denko Corporation
6.16 Noven Pharmaceuticals, Inc.
6.17 Pantec Biosolutions AG
6.18 Tapemark
6.19 tesa Labtec GmbH
6.20 TEVA Pharmaceutical Industries Ltd.
6.21 Zosano Pharma

7 TRANSMUCOSAL DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Transmucosal Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transmucosal Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transmucosal Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transmucosal Drug Delivery Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA TRANSMUCOSAL DRUG DELIVERY MARKET FORECAST (2018-2025)

11.1 EMEA Transmucosal Drug Delivery Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Transmucosal Drug Delivery Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Transmucosal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Transmucosal Drug Delivery Price and Trend Forecast (2018-2025)
11.2 EMEA Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Transmucosal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Transmucosal Drug Delivery Sales Forecast by Type (2018-2025)
11.7 EMEA Transmucosal Drug Delivery Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Transmucosal Drug Delivery
Figure EMEA Transmucosal Drug Delivery Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Transmucosal Drug Delivery Sales Volume Market Share by Type (Product Category) in 2017
Figure Passive Transdermal Drug Delivery Product Picture
Figure Active Transdermal Drug Delivery Product Picture
Figure EMEA Transmucosal Drug Delivery Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Transmucosal Drug Delivery by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Transmucosal Drug Delivery Market Size (Million USD) by Region (2013-2025)
Figure Europe Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Transmucosal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Transmucosal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Africa Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Transmucosal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Transmucosal Drug Delivery Sales Volume and Growth Rate (2013-2025)
Figure EMEA Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Transmucosal Drug Delivery Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Transmucosal Drug Delivery Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Transmucosal Drug Delivery Sales Share by Players (2013-2018)
Figure 2017 Transmucosal Drug Delivery Sales Share by Players
Figure 2017 Transmucosal Drug Delivery Sales Share by Players
Figure EMEA Transmucosal Drug Delivery Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Transmucosal Drug Delivery Revenue (Million USD) by Players (2013-2018)
Table EMEA Transmucosal Drug Delivery Revenue Share by Players (2013-2018)
Table 2017 EMEA Transmucosal Drug Delivery Revenue Share by Players
Table 2017 EMEA Transmucosal Drug Delivery Revenue Share by Players
Table EMEA Transmucosal Drug Delivery Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Transmucosal Drug Delivery Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Transmucosal Drug Delivery Sales Share by Type (2013-2018)
Figure Sales Market Share of Transmucosal Drug Delivery by Type (2013-2018)
Figure EMEA Transmucosal Drug Delivery Sales Market Share by Type (2013-2018)
Table EMEA Transmucosal Drug Delivery Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Transmucosal Drug Delivery Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Transmucosal Drug Delivery by Type in 2017
Table EMEA Transmucosal Drug Delivery Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Transmucosal Drug Delivery Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Transmucosal Drug Delivery Sales Share by Application (2013-2018)
Figure Sales Market Share of Transmucosal Drug Delivery by Application (2013-2018)
Figure EMEA Transmucosal Drug Delivery Sales Market Share by Application in 2017
Table EMEA Transmucosal Drug Delivery Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Transmucosal Drug Delivery Sales Share by Region (2013-2018)
Figure Sales Market Share of Transmucosal Drug Delivery by Region (2013-2018)
Figure EMEA Transmucosal Drug Delivery Sales Market Share in 2017
Table EMEA Transmucosal Drug Delivery Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Transmucosal Drug Delivery Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Transmucosal Drug Delivery by Region (2013-2018)
Figure EMEA Transmucosal Drug Delivery Revenue Market Share Regions in 2017
Table EMEA Transmucosal Drug Delivery Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Transmucosal Drug Delivery Revenue and Growth Rate (2013-2018)
Table Europe Transmucosal Drug Delivery Sales (K Units) by Type (2013-2018)
Table Europe Transmucosal Drug Delivery Market Share by Type (2013-2018)
Figure Europe Transmucosal Drug Delivery Market Share by Type in 2017
Table Europe Transmucosal Drug Delivery Sales (K Units) by Application (2013-2018)
Table Europe Transmucosal Drug Delivery Market Share by Application (2013-2018)
Figure Europe Transmucosal Drug Delivery Market Share by Application in 2017
Table Europe Transmucosal Drug Delivery Sales (K Units) by Countries (2013-2018)
Table Europe Transmucosal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Europe Transmucosal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Europe Transmucosal Drug Delivery Sales Market Share by Countries in 2017
Table Europe Transmucosal Drug Delivery Revenue (Million USD) by Countries (2013-2018)
Table Europe Transmucosal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Europe Transmucosal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Europe Transmucosal Drug Delivery Revenue Market Share by Countries in 2017
Figure Germany Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure France Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure UK Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Transmucosal Drug Delivery Sales (K Units) by Type (2013-2018)
Table Middle East Transmucosal Drug Delivery Market Share by Type (2013-2018)
Figure Middle East Transmucosal Drug Delivery Market Share by Type (2013-2018)
Table Middle East Transmucosal Drug Delivery Sales (K Units) by Applications (2013-2018)
Table Middle East Transmucosal Drug Delivery Market Share by Applications (2013-2018)
Figure Middle East Transmucosal Drug Delivery Sales Market Share by Application in 2017
Table Middle East Transmucosal Drug Delivery Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Transmucosal Drug Delivery Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Transmucosal Drug Delivery Sales Volume Market Share by Countries in 2017
Table Middle East Transmucosal Drug Delivery Revenue (Million USD) by Countries (2013-2018)
Table Middle East Transmucosal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Middle East Transmucosal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Middle East Transmucosal Drug Delivery Revenue Market Share by Countries in 2017
Figure Saudi Arabia Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Transmucosal Drug Delivery Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Transmucosal Drug Delivery Sales (K Units) by Type (2013-2018)
Table Africa Transmucosal Drug Delivery Sales Market Share by Type (2013-2018)
Figure Africa Transmucosal Drug Delivery Sales Market Share by Type (2013-2018)
Figure Africa Transmucosal Drug Delivery Sales Market Share by Type in 2017
Table Africa Transmucosal Drug Delivery Sales (K Units) by Application (2013-2018)
Table Africa Transmucosal Drug Delivery Sales Market Share by Application (2013-2018)
Figure Africa Transmucosal Drug Delivery Sales Market Share by Application (2013-2018)
Table Africa Transmucosal Drug Delivery Sales Volume (K Units) by Countries (2013-2018)
Table Africa Transmucosal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Africa Transmucosal Drug Delivery Sales Market Share by Countries (2013-2018)
Figure Africa Transmucosal Drug Delivery Sales Market Share by Countries in 2017
Table Africa Transmucosal Drug Delivery Revenue (Million USD) by Countries (2013-2018)
Table Africa Transmucosal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Africa Transmucosal Drug Delivery Revenue Market Share by Countries (2013-2018)
Figure Africa Transmucosal Drug Delivery Revenue Market Share by Countries in 2017
Figure South Africa Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Table 3M Pharmaceuticals Transmucosal Drug Delivery Basic Information List
Table 3M Pharmaceuticals Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Pharmaceuticals Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure 3M Pharmaceuticals Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure 3M Pharmaceuticals Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Acrux Limited Transmucosal Drug Delivery Basic Information List
Table Acrux Limited Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Acrux Limited Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Acrux Limited Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Acrux Limited Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table ALZA Corporation Transmucosal Drug Delivery Basic Information List
Table ALZA Corporation Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure ALZA Corporation Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure ALZA Corporation Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure ALZA Corporation Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Antares Pharma, Inc. Transmucosal Drug Delivery Basic Information List
Table Antares Pharma, Inc. Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Antares Pharma, Inc. Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Antares Pharma, Inc. Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Antares Pharma, Inc. Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Apricus BioSciences, Inc Transmucosal Drug Delivery Basic Information List
Table Apricus BioSciences, Inc Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Apricus BioSciences, Inc Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Apricus BioSciences, Inc Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Aveva Drug Delivery Systems Transmucosal Drug Delivery Basic Information List
Table Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Aveva Drug Delivery Systems Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Corium International, Inc Transmucosal Drug Delivery Basic Information List
Table Corium International, Inc Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Corium International, Inc Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Corium International, Inc Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Corium International, Inc Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table DURECT Corporation Transmucosal Drug Delivery Basic Information List
Table DURECT Corporation Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure DURECT Corporation Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure DURECT Corporation Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure DURECT Corporation Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Generex Biotechnology Corporation Transmucosal Drug Delivery Basic Information List
Table Generex Biotechnology Corporation Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Generex Biotechnology Corporation Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Generex Biotechnology Corporation Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Basic Information List
Table Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Sales (K Units) and Growth Rate (2013-2018)
Figure Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Sales Market Share in EMEA (2013-2018)
Figure Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue Market Share in EMEA (2013-2018)
Table Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Basic Information List
Table MedPharm LTD Transmucosal Drug Delivery Basic Information List
Table Mylan, Inc. Transmucosal Drug Delivery Basic Information List
Table Nemaura Pharma Ltd Transmucosal Drug Delivery Basic Information List
Table Nitto Denko Corporation Transmucosal Drug Delivery Basic Information List
Table Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Basic Information List
Table Pantec Biosolutions AG Transmucosal Drug Delivery Basic Information List
Table Tapemark Transmucosal Drug Delivery Basic Information List
Table tesa Labtec GmbH Transmucosal Drug Delivery Basic Information List
Table TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Basic Information List
Table Zosano Pharma Transmucosal Drug Delivery Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transmucosal Drug Delivery
Figure Manufacturing Process Analysis of Transmucosal Drug Delivery
Figure Transmucosal Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Transmucosal Drug Delivery Major Manufacturers in 2017
Table Major Buyers of Transmucosal Drug Delivery
Table Distributors/Traders List
Figure EMEA Transmucosal Drug Delivery Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Transmucosal Drug Delivery Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Transmucosal Drug Delivery Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Transmucosal Drug Delivery Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Transmucosal Drug Delivery Sales Market Share Forecast by Region (2018-2025)
Table EMEA Transmucosal Drug Delivery Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Transmucosal Drug Delivery Revenue Market Share Forecast by Region (2018-2025)
Table Europe Transmucosal Drug Delivery Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Transmucosal Drug Delivery Sales Market Share Forecast by Countries (2018-2025)
Table Europe Transmucosal Drug Delivery Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Transmucosal Drug Delivery Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Transmucosal Drug Delivery Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Transmucosal Drug Delivery Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Transmucosal Drug Delivery Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Transmucosal Drug Delivery Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Transmucosal Drug Delivery Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Transmucosal Drug Delivery Sales Market Share Forecast by Countries (2018-2025)
Table Africa Transmucosal Drug Delivery Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Transmucosal Drug Delivery Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Transmucosal Drug Delivery Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Transmucosal Drug Delivery Sales Market Share Forecast by Type (2018-2025)
Table EMEA Transmucosal Drug Delivery Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Transmucosal Drug Delivery Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources